PharmaPoint: Acute Coronary Syndrome – Current and Future Players Size, Share, Growth, Analysis, Trends and Forecast

Coronary Syndrome

Coronary Syndrome

“The Report PharmaPoint: Acute Coronary Syndrome – Current and Future Players provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

View Full Report :

GlobalData has released its pharma report, PharmaPoint: Acute Coronary Syndrome Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global ACS market. The report provides insight into the competitive ACS landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts.


Investigation of current and future market competition for ACS

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of ACS sector through market impact analysis, future market scenario and company analysis

Download Sample copy of this Report at :

Reasons to buy

Gain a high level view of the trends shaping and driving ACS market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Whats the next big thing in the global ACS market landscape? Identify, understand and capitalize

Send An Enquiry Request :

Table of Contents

1 Table of Contents 8

1.1 List of Tables10

1.2 List of Figures 11

2 Introduction 12

2.1 Catalyst 12

2.2 Related Reports 13

2.3 Upcoming Related Reports 15

3 Market Outlook 16

3.1 Global Markets 16

3.1.1 Forecast 16

3.1.2 Drivers and Barriers – Global Issues 26

4 Current and Future Players 32

4.1 Overview 32

4.2 Trends in Corporate Strategy 38

4.3 Company Profiles 40

4.3.1 Amgen 40

4.3.2 AstraZeneca 42

4.3.3 Bristol-Myers Squibb 45

4.3.4 Daiichi Sankyo 48

4.3.5 Eli Lilly 50

4.3.6 GlaxoSmithKline 52

4.3.7 Janssen Pharmaceuticals (Johnson & Johnson) 55

4.3.8 The Medicines Company 56

4.3.9 Merck & Co. 60

4.3.10 Pfizer 63

4.3.11 Sanofi 66

5 Appendix 70

5.1 Bibliography 70

5.2 Abbreviations 72

5.3 Methodology 76

5.4 Forecasting Methodology 76

5.4.1 Methodology for Forecasting Selected Portions of the Diagnosed Prevalent ACS Population 76

5.4.2 Diagnosed Acute Coronary Syndrome Patients 77

5.4.3 Percent Drug-Treated Patients 78

5.4.4 General Pricing Assumptions 78

5.4.5 Generic Erosion 79

5.4.6 Pricing of Pipeline Agents 80

5.5 Physicians and Specialists Included in this Study 81

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by
%d bloggers like this: